Litcius/Paper detail

Considerations for design, manufacture, and delivery for effective and safe T-cell engager therapies

Tara Arvedson, Julie M. Bailis, Thomas Urbig, Jennitte Stevens

2022Current Opinion in Biotechnology33 citationsDOI

Topics & Concepts

BlinatumomabImmunotherapyCD19Cancer researchMedicinePharmacologyInternal medicineImmunologyAntigenCancerCAR-T cell therapy researchNanowire Synthesis and ApplicationsRNA Interference and Gene Delivery
Considerations for design, manufacture, and delivery for effective and safe T-cell engager therapies | Litcius